Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT00825955||Terminated||Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment||
||587||All||18 Years and older (Adult, Older Adult)||NCT00825955||CA182-034
EUDRACT #: 2008-005084-34
|BRISK PS||February 17, 2009||November 15, 2011||August 25, 2017||January 21, 2009||August 21, 2018||